- Home
- Applications
- europe
- type 1 diabetes
Show results for
Refine by
Type 1 Diabetes Product Applications In Europe
4 applications found
a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. https://www.bocsci.com/saxagliptin-impurity-15-cas-1496712-39-0-item-479445.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
An impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
The increase or decrease of a natural immune response to obtain a therapeutic result is the basis of immunotherapy. It holds great promise for the treatment of autoimmune diseases, cancer, and the prevention of transplant ...
ByNanovex Biotechnologies based in Llanera, SPAIN